Abstract:Delong Li, 1 Debin Meng, 1, 2 Rungui Niu 1 1 Department of Special Geriatrics, Shanxi Cancer Hospital, Taiyuan, Shanxi, People's Republic of China; 2 Department of General Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi, People's Republic of China Correspondence: Debin Meng Department of Special Geriatrics, Shanxi Cancer Hospital, No. 3 Worker Street of Xinghualing District, Taiyuan City, Shanxi Province, People's Republic of China Email debinmengsx@sina.com Introduction: Non-small lung cancer (NSCLC) is one of the most common malignant tumors in the world. Chemoresistance is the main reason of adverse effects leading to the death of patients; thus, it is important to discover the potential target of chemotherapeutic resistance. Methods: The expression of differentially expressed miRNA was detected in BEAS-2B, A549 and A549/cisplatin (DDP) by qRT-PCR. Transmission electron microscopy (TEM) and exosome biomarkers were used to validate the extracted exosome. Cells incubated with miR-613 enriched exosomes were used to detect the function of exo-miR-613 in vitro. Then, exo-miR-613 was injected to mice treated with DDP to investigate the function role of exo-miR-613 in vivo. Results: Comparing to BEAS-2B, the expression of miR-613 inA549 was significantly reduced, which was more obvious in A549/DDP. After incubated with exo-miR-613 and corresponding exo-negative control (NC), we found overexpression of miR-613 remarkably increased the inhibition of cell proliferation induced by cisplatin. Exo-miR-613 fused into cells to significantly enhance the inhibited effect of DDP on the proliferation, migration and showed a promotion on cell apoptosis and DNA damage. The in vivo study showed that exo-miR-613 significantly inhibited the tumor growth, and promote the sensitivity to DDP, probably by down-regulating the expressions of GJA1, TBP and EIF-4E in tumor cells and tissues. Conclusion: Exo-miR-613 reversed chemoresistance to DDP in NSCLC cell to involve in the process of tumor progression, and might be a potential therapeutic strategy for NSCLC. Keywords: exosome, miRNA, non-small cell lung cancer, cisplatin, chemoresistance, apoptosis

Enhanced Cisplatin Cytotoxicity by RNA Interfering the Excision Repair Cross-complementing Gene 1 in Lung Cancer Cell A549/DDP

Enhanced Cisplatin Cytotoxicity by RNA Interfering the Excision Repair Cross-Complementing 1 Gene in Ovarian Cancer Cell Lines

ERCC1 targeted RNA interference reversing cisplatin resistance in human lung adeno-carcinoma cells

Ercc1 Sirna Ameliorates Drug Resistance to Cisplatin in Gastric Carcinoma Cell Lines

[Relationship Between ERCC1 Expression and Cisplatin Intervention in Human Lung Adenocarcinoma Cell Lines].

Study of RNAi Targeting Epidermal Growth Factor Receptor on Lung Adenocarcinoma A549 Cell Line Growth and Sensitivity to Cisplatin

[Relationship Between Nucleotide Excision Repair Gene ERCC1 and Resistance to Cisplatin in Ovarian Cancer].

MicroRNA-191 Modulates Cisplatin-Induced DNA Damage Response by Targeting RCC2.

Sensitization To The Cytotoxicity Of Cisplatin By Transfection With Nucleotide Excision Repair Gene Xeroderma Pigmentosun Group A Antisense Rna In Human Lung Adenocarcinoma Cells

[Enhancement Effect of Nucleotide Excision Repair Gene Xeroderma Pigmentosun Group a Antisense RNA on Sensitivity of Human Lung Adenocarcinoma Cell Line A549 to Cisplatin].

Targeting ERCC2 with Sirna Self-Assembled Nanoparticles to Enhance the Cisplatin Response in Bladder Cancer

[RNA Interference Targeting GRP75 Decreases Cisplatin Resistance in Human Lung Adenocarcinoma Cell].

Knockdown of Insulin-Like Growth Factor 1 Receptor Enhances Chemosensitivity to Cisplatin in Human Lung Adenocarcinoma A549 Cells

Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy

Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)

Integrative PDGF/PDGFR and focal adhesion pathways are downregulated in ERCC1-defective non-small cell lung cancer undergoing sodium glycididazole-sensitized cisplatin treatment

Upregulation of Microrna-451 Increases Cisplatin Sensitivity of Non-Small Cell Lung Cancer Cell Line (A549)

A Pirna-Like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma

Enhancement of Cisplatin-Induced Cytotoxicity Against Cervical Cancer Spheroid Cells by Targeting Long Non-Coding RNAs.

Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613

Enhancement of Cisplatin Sensitivity in Lung Cancer Xenografts by Liposome-Mediated Delivery of the Plasmid Expressing Small Hairpin RNA Targeting Survivin.